semaglutide knoxville tn Flex-Dose 3 mL Injectable 2.5 mg/mL TennCare's obesity medication coverage is

GLP-1 prescriptions increase by 364% whilst BMS declines by 42% owenhaskins May 28, 2025 5 min read Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to a FAIR Health white paper entitled, Obesity and GLP-1 Drugs: A Claims-Based Analysis

Sourcing matters when it comes to peptides, and BioLongevity Labs makes it simple

These medications reduce appetite, help regulate blood sugar, and make it easier to stay consistent

At MedShape weight Loss Clinic, we often start patients on semaglutide or tirzepatide if they are facing intolerable side effects or have hit a plateau with their weight loss